Insufficient scRNA-seq data for expression of SHLD3 at single-cell level.
Insufficient scRNA-seq data for expression of SHLD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 206.18 | 245 / 245 | 100% | 7.78 | 502 / 502 |
esophagus | 100% | 96.25 | 1444 / 1445 | 100% | 3.99 | 183 / 183 |
brain | 100% | 124.09 | 2636 / 2642 | 100% | 5.48 | 705 / 705 |
breast | 100% | 113.20 | 459 / 459 | 100% | 4.89 | 1115 / 1118 |
ovary | 100% | 104.68 | 180 / 180 | 100% | 4.41 | 428 / 430 |
thymus | 100% | 132.66 | 652 / 653 | 99% | 4.44 | 601 / 605 |
uterus | 100% | 101.54 | 170 / 170 | 99% | 5.30 | 455 / 459 |
stomach | 100% | 100.14 | 359 / 359 | 99% | 4.41 | 283 / 286 |
lung | 99% | 120.29 | 572 / 578 | 100% | 4.74 | 1154 / 1155 |
bladder | 100% | 86.10 | 21 / 21 | 99% | 4.13 | 498 / 504 |
adrenal gland | 100% | 132.92 | 258 / 258 | 98% | 4.15 | 226 / 230 |
intestine | 100% | 129.56 | 966 / 966 | 98% | 4.44 | 515 / 527 |
pancreas | 99% | 71.57 | 326 / 328 | 98% | 3.54 | 175 / 178 |
kidney | 100% | 123.81 | 89 / 89 | 97% | 3.31 | 877 / 901 |
liver | 100% | 92.90 | 226 / 226 | 96% | 3.20 | 391 / 406 |
skin | 99% | 105.17 | 1794 / 1809 | 90% | 4.07 | 425 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.63 | 29 / 29 |
spleen | 100% | 188.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.04 | 1 / 1 |
adipose | 100% | 113.20 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 83.06 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 75.00 | 843 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 76.54 | 1303 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 72.89 | 718 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 1.72 | 50 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000042 | Biological process | negative regulation of double-strand break repair via homologous recombination |
GO_0006281 | Biological process | DNA repair |
GO_0002208 | Biological process | somatic diversification of immunoglobulins involved in immune response |
GO_0045830 | Biological process | positive regulation of isotype switching |
GO_2001034 | Biological process | positive regulation of double-strand break repair via nonhomologous end joining |
GO_0043247 | Biological process | telomere maintenance in response to DNA damage |
GO_0005730 | Cellular component | nucleolus |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005515 | Molecular function | protein binding |
Gene name | SHLD3 |
Protein name | Shieldin complex subunit 3 (REV7-interacting novel NHEJ regulator 1) (Shield complex subunit 3) |
Synonyms | FLJ26957 RINN1 |
Description | FUNCTION: Component of the shieldin complex, which plays an important role in repair of DNA double-stranded breaks (DSBs). During G1 and S phase of the cell cycle, the complex functions downstream of TP53BP1 to promote non-homologous end joining (NHEJ) and suppress DNA end resection. Mediates various NHEJ-dependent processes including immunoglobulin class-switch recombination, and fusion of unprotected telomeres. . |
Accessions | ENST00000510585.3 Q6ZNX1 |